Company Filing History:
1 out of 2,405 
1 out of 8 Years Active: 2013
Title: Cinzia Traboni: Innovator in HCV Research
Introduction
Cinzia Traboni is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of hepatitis C virus (HCV) research. Her work focuses on enhancing the functionality of HCV replicons, particularly those containing the NS5B protein from genotype 2B.
Latest Patents
Cinzia Traboni holds a patent for "HCV replicons containing NS5B from genotype 2B." This invention features methods for improving the ability of a genotype 2B NS5B sequence to function within a replicon. It also outlines processes for producing replicons that contain a functional genotype 2B NS5B. Furthermore, the patent discusses the use of these replicons to measure the impact of compounds on HCV replication sustained by the genotype 2B polymerase. The invention includes a genotype 1B NS4B adaptive mutation, demonstrating the ability to create chimeric replicons based on HCV genotype 1B, where most of the NS5B sequence is replaced with that of genotype 2B.
Career Highlights
Cinzia Traboni has worked with notable organizations, including Merck Sharp & Dohme Corporation and Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.a. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Cinzia has collaborated with esteemed colleagues such as Steven W. Ludmerer and Donald J. Graham. These partnerships have enriched her research and expanded the impact of her work in the field of HCV.
Conclusion
Cinzia Traboni is a dedicated inventor whose work in HCV research has led to significant advancements in understanding and combating the virus. Her innovative approaches and collaborations continue to influence the field positively.